# ulcerative colitis (UC) - grok-4.6

- Benchmark system: E2seq + Agent RAG
- Repeat: 2
- Task type: DISEASE-STATE
- Tissue / sample source: colonic mucosal tissue
- Comparison or endpoint: ulcerative colitis versus healthy control
- Answer input cohort: Discovery/Core only
- Selected items: 100
- Input fields: gene name, effect size (log2FC/HR), P value, FDR
- E2seq Agent RAG: enabled
- Conversation memory: disabled
- Thinking mode: disabled
- Held-out validation data in prompt/RAG: no
- Model API: xAI / grok-4.6
- Message SHA-256: 478acec7ab00f0e9bda085b6ecab7aa16a2bc8aa5cde3f2ba8fb71b2af94f79a
- Response HTTP status: 200
- Prompt tokens: 33534
- Completion tokens: 7196
- Reasoning tokens: 3624
- Total tokens: 40730
- API requests reported: 2
- Elapsed seconds: 76.993
- RAG status: reused_or_ready
- RAG records/genes reported: 100
- RAG elapsed seconds: 1095.213
- Question handoff seconds: 1109.559
- Final benchmark system: E2seq; file rank 2/5; original repeat 2; model vendor: xAI

---
**Overall biological interpretation**  
The transcriptomic profile in UC colonic mucosa shows a dominant pro-inflammatory mucosal response, including chemokine-driven neutrophil recruitment, innate immune activation, and compensatory IL-1/IL-17 signaling, coordinated with widespread downregulation of epithelial solute and water transporters. This pattern aligns with active disease pathology involving barrier disruption, fluid imbalance, and chronic tissue remodeling. Upregulated genes (40 total) cluster around immune signaling and matrix dynamics, while 60 downregulated genes implicate impaired transepithelial transport and homeostasis.

**Core biological programs**  

**Program 1: Chemokine-driven inflammatory signaling**  
Direction: upregulated  
Major supporting genes: CXCL1, CXCL2, CXCL3, SOCS3, IL1RN, IRAK3  
Most appropriate pathway: KEGG IL-17 signaling pathway  
Supporting genes collectively indicate this program because CXCL ligands promote neutrophil chemotaxis and tissue infiltration, IL1RN antagonizes IL-1 signaling, IRAK3 mediates IL-1R/TLR signaling, and SOCS3 provides negative feedback on cytokine pathways; their coordinated upregulation reflects the core immune amplification in UC.  
Evidence strength: direct from input dataset (multiple independent genes with FDR < 1e-11) + supplied KEGG/Reactome annotation and STRING edges (CXCL1–CXCL2–CXCL3 network).  
Limitations: directionally concordant only; no independent-cohort statistic supplied.

**Program 2: Impaired fluid, water, and carboxylic-acid transport**  
Direction: predominantly downregulated  
Major supporting genes: AQP7, AQP8, SLC23A1, SLC51A, SLC19A3, SLC38A4, ABCG2  
Most appropriate pathway: GO:0042044 (Fluid Transport), GO:0006833 (Water Transport), KEGG Bile secretion  
Supporting genes collectively indicate this program because aquaporins and SLC carriers mediate transepithelial water and small-molecule movement; their downregulation impairs colonic fluid absorption and bile-acid homeostasis, consistent with diarrhea and mucosal dehydration in active UC.  
Evidence strength: direct from input dataset (multiple genes, FDR < 1e-19) + supplied GO/KEGG batch enrichment for transport terms and Reactome records on AQP7/8 function.  
Limitations: mixed directionality (SLC6A14 upregulated); no cell-type purity data to distinguish epithelial vs. inflammatory contributions.

**Program 3: Antimicrobial defense and innate immune activation**  
Direction: upregulated  
Major supporting genes: LCN2, REG4, DUOX2, S100A8, DEFB1  
Most appropriate pathway: Reactome Neutrophil degranulation / Metal sequestration by antimicrobial proteins  
Supporting genes collectively indicate this program because LCN2 and S100A8 sequester iron to limit microbial growth, REG4 functions as an antimicrobial lectin, and DUOX2 generates H₂O₂ for pathogen killing; the module reflects heightened epithelial innate immunity and neutrophil degranulation in inflamed mucosa.  
Evidence strength: direct from input dataset (multiple genes, FDR < 1e-20) + supplied Reactome/STRING links (e.g., LCN2–MMP9, LCN2–CTLA4).  
Limitations: individual literature associations exist but do not constitute independent replication in this cohort.

**Program 4: Mucosal extracellular-matrix remodeling**  
Direction: upregulated  
Major supporting genes: TNC, MMP3, TIMP1, PRRX1, CDH3  
Most appropriate pathway: KEGG Rheumatoid arthritis (shared ECM and immune modules)  
Supporting genes collectively indicate this program because TNC and MMP3 promote matrix degradation and fibroblast activation, TIMP1 balances proteolysis, PRRX1 drives mesenchymal transition, and CDH3 regulates adhesion; these signals indicate chronic tissue remodeling and fibrosis risk in UC.  
Evidence strength: direct from input dataset (multiple genes) + supplied STRING edges (TNC–ITGB1, MMP3 co-membership).  
Limitations: broad pathway overlap with RA; no disease-stage stratification supplied.

**Key genes and interaction modules**  
- **LCN2 (up, log2FC 2.67)**: antimicrobial iron sequestration; STRING co-expression with MMP9/CTLA4; pathway co-membership in neutrophil degranulation.  
- **DUOX2 (up, log2FC 4.67)**: H₂O₂-producing oxidase for microbial killing; direct dataset evidence; putative regulatory link to REG4 via oxidative stress.  
- **CXCL1 (up, log2FC 3.46)**: neutrophil chemoattractant; STRING network with CXCR2; co-expression with CXCL2/3 (regulatory interaction via chemokine signaling).  
- **AQP7 (down, log2FC −2.32)**: water channel; GO Fluid Transport; STRING co-membership with AQP8 (pathway co-membership).  
- **IL1RN (up, log2FC 2.88)**: IL-1 receptor antagonist; direct dataset evidence; regulatory interaction with IRAK3.  
- **REG4 (up, log2FC 2.05)**: antimicrobial lectin; direct dataset evidence; indirect link to LCN2 via microbial sensing (co-expression).  
- **MMP3 (up, log2FC 4.64)**: matrix metalloproteinase; STRING with TNC/ITGB1; pathway co-membership in ECM remodeling (direct physical interaction with TIMP1).  
- **TNC (up, log2FC 2.58)**: tenascin-C; STRING ITGB1 interaction; co-expression with CDH3 (regulatory interaction).  
- **SOCS3 (up, log2FC 2.79)**: SOCS family feedback regulator; direct dataset evidence; co-expression with IRAK3/CXCLs.  
- **CTLA4 (up, log2FC 2.62)**: immune-checkpoint regulator; STRING with LCN2; co-membership in mucosal tolerance module (co-expression).

**Validation priorities**  
1. **LCN2, DUOX2, and CXCL1 expression by qRT-PCR or proteomics in independent UC cohorts** (Biomarker). Prioritized because multiple dataset genes converge on antimicrobial/chemokine axes with known UC literature support; current evidence is directional only. Next step: larger matched cohort with clinical metadata. External evidence supports roles in IBD but lacks UC-specific replication.  
2. **Functional rescue of AQP7/AQP8 in colonic organoids or mouse DSS model** (Mechanistic hypothesis). Prioritized due to strong transport-program signal and GO enrichment; external literature supports aquaporin roles in IBD. Next step: CRISPR editing and fluid-transport assays.  
3. **IL1RN and IRAK3 as anti-inflammatory drug targets** (Therapeutic target). Prioritized because dataset upregulation suggests compensatory response; no drug-target claim can be made from association alone. Next step: CRISPR validation of IL1RN knockout in human UC organoids. External evidence (PMID 40918148) links IRAK3 to inflammatory diseases but does not establish causality in UC.  
4. **STRING-validated CXCL1–CXCL3–SOCS3 network perturbation** (Interaction/network hypothesis). Prioritized by supplied STRING edges and co-expression; limited external interaction evidence. Next step: proximity ligation or co-IP in patient biopsies.  
5. **Cell-composition deconvolution to separate epithelial vs. immune-cell contributions** (Confounding or composition check). Prioritized because inflammatory infiltrates can drive both chemokine and transport signals; no purity metric supplied. Next step: CIBERSORT or single-cell RNA-seq on matched biopsies. External evidence from PMID 41029776 supports biomarker potential but requires replication.

**Evidence grounding**  
All statistical directions, log2FC, P, and FDR values derive directly from the supplied input table and statistical ledger (100 genes, FDR < 1e-11). Pathway and network annotations come from supplied GO/KEGG/Reactome/STRING batch records and external databases; these are contextual, not statistical. No independent-cohort replication statistics are present, so external records (e.g., Europe PMC articles on UC biomarkers and IRAK3) are used only for plausibility and relationship type (co-expression, pathway co-membership, STRING edges). Sources within the same database (e.g., multiple Reactome entries) are not treated as independent.

**Limitations and alternative explanations**  
- Inflammatory cell infiltration may inflate chemokine and neutrophil-degranulation signals; deconvolution or laser-capture microdissection could distinguish epithelial vs. immune contributions.  
- Disease severity and treatment exposure (e.g., steroids, biologics) are unaccounted for and could alter transport-gene expression.  
- Batch or platform effects cannot be excluded without external cohort comparison.  
- IG-cluster upregulation may reflect plasma-cell infiltration rather than epithelial changes.  
- Broad transport-program downregulation could partly reflect cell-type shifts (e.g., reduced goblet cells) rather than pure epithelial dysfunction. Association-versus-causation ambiguity remains because no causal evidence is supplied.

E2seq statistical audit: selected=100, ledger=100, RAG records=100, numeric claims checked=9, external claims checked=0, external mismatches=0, status=passed.

Answer model API: xAI / grok-4.6

Source coverage (gene sources = selected items with records / selected RAG items; literature sources = articles / queries)
Online APIs: alliance 94/100 selected items (records returned); cbioportal 87/100 selected items (records returned); chembl 40/100 selected items (partially returned; some queries failed); civic 7/100 selected items (records returned); clinicaltrials 51/100 selected items (records returned); clinvar 90/100 selected items (records returned); ensembl 55/100 selected items (partially returned; some queries failed); europepmc 936 articles / initial full-cohort RAG 100 queries + 4 current-round queries; gtex 91/100 selected items (records returned); gwas 100/100 selected items (records returned); hpa 85/100 selected items (records returned); humanbase 87/100 selected items (records returned); intact 85/100 selected items (records returned); mygene 93/100 selected items (records returned); omnipath 45/100 selected items (records returned); opentargets 92/100 selected items (records returned); pubmed 750 articles / initial full-cohort RAG 100 queries + 3 current-round queries; quickgo 87/100 selected items (records returned); reactome 100/100 selected items (records returned); uniprot 88/100 selected items (records returned)
Local databases: gutmgene 8/100 selected items (records returned); hmdb 46/100 selected items (records returned); string 85/100 selected items (records returned); trrust 31/100 selected items (records returned)
